Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 350 of 3499 entries
View as:

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02610413 Org: User:
Start: 03/25/14 End: 01/01/00 Due: 01/01/01

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02888743 Org: User:
Start: 08/14/17 End: 01/02/26 Due: 01/02/27

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00096265 Org: User:
Start: 10/06/04 End: 04/01/12 Due: 04/01/13

Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00063947 Org: User:
Start: 05/31/03 End: - Due: -

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01077453 Org: User:
Start: 03/31/10 End: - Due: -

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT00045110 Org: User:
Start: 08/31/02 End: 12/31/10 Due: 12/31/11

Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02899728 Org: User:
Start: 03/30/18 End: 03/17/20 Due: 03/17/21

Molecular Staging of Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00340808 Org: User:
Start: 03/19/04 End: 07/16/20 Due: 07/16/21

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT03196180 Org: User:
Start: 10/15/19 End: 08/02/24 Due: 08/02/25

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00033618 Org: User:
Start: 11/30/02 End: - Due: -

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT02326805 Org: User:
Start: 06/03/15 End: 07/20/22 Due: 07/20/23

7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00301938 Org: User:
Start: 12/31/05 End: - Due: -

Family Study of Head and Neck Cancers in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00342147 Org: User:
Start: 11/07/95 End: 06/05/20 Due: 06/05/21

Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01232829 Org: User:
Start: 10/31/10 End: 05/31/14 Due: 05/31/15

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00004853 Org: User:
Start: 03/03/00 End: 05/20/09 Due: 05/20/10

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00408694 Org: User:
Start: 12/13/06 End: 12/15/11 Due: 12/15/12

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04432597 Org: User:
Start: 08/11/20 End: 11/20/25 Due: 11/20/26

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00262847 Org: User:
Start: 09/30/05 End: 04/30/15 Due: 04/30/16

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT05918055 Org: User:
Start: 11/14/23 End: 03/10/25 Due: 03/10/26

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

Phase: N/A Priority: Normal
NCT ID: NCT03604978 Org: User:
Start: 06/17/19 End: 11/30/25 Due: 11/30/26

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Phase: N/A Priority: Normal
NCT ID: NCT02839694 Org: User:
Start: 07/07/16 End: 04/26/17 Due: 04/26/18

MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01263145 Org: User:
Start: 01/05/11 End: 10/19/12 Due: 10/19/13

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Phase: N/A Priority: Normal
NCT ID: NCT02322190 Org: User:
Start: 12/20/14 End: 10/31/19 Due: 10/31/20

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02858310 Org: User:
Start: 01/27/17 End: 01/01/26 Due: 01/01/27

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00033137 Org: User:
Start: 05/13/02 End: - Due: -